Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06037785 · ClinicalTrials.gov registry record · NA

Self-Management Interventions After an ICD Shock

A NA study of PTSD and Stress Reaction, sponsored by University of Washington.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06037785: Recruiting NA study of PTSD and Stress Reaction, sponsored by University of Washington.

NCT06037785 is a NA study of PTSD and Stress Reaction that is actively recruiting participants, run by University of Washington. The registered enrollment target is 60 participants, below the 302-participant average among 154 other PTSD trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06037785, a NA study of PTSD and Stress Reaction, is actively recruiting participants, sponsored by University of Washington.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

This study, "Biobehavioral Intervention to Reduce PTSD Symptoms After an ICD Shock," addresses a critical need in cardiology care by describing the feasibility and acceptability of a timely, highly promising, electronically-delivered intervention for patients who have recently received an ICD delivered shock. The study intervention and outcomes are designed to reduce anxiety, enhance return to activities of daily living (ADLs), and prevent the development of severe distress and post-traumatic stress disorder (PTSD), and ultimately promote quality of life. The study is a two-arm, embedded mixed methods, randomized trial (N=60, 30/group). The purpose is to determine feasibility and potential effects of a self-management intervention (SPSM) plus usual care (UC) compared to UC alone, delivered during the critical 1 month period after an ICD shock when distress is high. The intervention will be delivered over 1 month following an ICD shock; a 6-month follow-up will be used to assess the sustainability of intervention effects and determine if the incidence of PTSD is reduced. SPSM includes: 1) training in heart rate (HR) self-monitoring; and 2) individualized learning through 4 self-paced, web-based modules. The study interventions are delivered at a crucial time, closely after an ICD shock when stress is high, but PTSD has not yet developed. The specific aims are to: 1) examine the effects of the SPSM intervention plus UC vs. UC alone on the primary outcome of ICD shock anxiety at 1 and 6 months post-shock event, 2) describe the impact of SPSM plus UC compared to UC alone on the secondary outcomes of total daily physical activity, depression, PTSD symptoms, QOL, salivary cortisol levels, and self-efficacy and outcome expectations at 1 and 6 months post-shock event, and 3) assess feasibility, acceptability, and safety of the SPSM intervention, SDOH will be used to describe differential responses to the SPSM intervention. This study fills a significant gap in the care of p

Primary Outcome

Florida Shock Anxiety Scale: range 1-50, higher is higher anxiety.

Interventions

  • BEHAVIORAL Self-Paced Self-Management (SPSM)

Study Locations (1)

Washington

  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2024-10-01
Est. Completion 2026-07-31
Phase NA
University of Washington

1,048 total trials

What NCT06037785 shows while recruiting

NCT06037785 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 302-participant average among 154 other PTSD trials with a reported enrollment target (80% lower).

The record links to 5 conditions, with PTSD appearing as the primary indexed condition, and to 1 intervention - of which Self-Paced Self-Management (SPSM) is the first listed.

NCT06037785 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT06037785 about?

NCT06037785 is a clinical study titled "Self-Management Interventions After an ICD Shock". This study, "Biobehavioral Intervention to Reduce PTSD Symptoms After an ICD Shock," addresses a critical need in cardiology care by describing the feasibility and acceptability of a timely, highly promising, electronically-delivered intervention for patients who have recently received an ICD delive...

What is the current status of trial NCT06037785?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-10-01. Estimated completion is 2026-07-31.

What conditions does trial NCT06037785 study?

This clinical trial studies the following conditions: PTSD, Stress Reaction, Implantable Defibrillator User, Stress Management, Social Cognitive Theory.

What interventions are being tested in trial NCT06037785?

The interventions under investigation include: Self-Paced Self-Management (SPSM) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06037785?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06037785 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for PTSD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06037785's enrollment target sits among peer trials

60 87th of 154 higher than 65 of 154 other PTSD trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other PTSD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06037785, the US trial registry maintained by the National Library of Medicine. NCT06037785 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.